CERO THERAPEUTICS HOLDINGS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$19.92 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-04-15
- CERO THERAPEUTICS HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$19.92M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 11 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|
| 2025-12-31 | -$19.92M 10-K · filed 2026-04-15 | |
| 2024-12-31 | -$8.30M 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |